Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025	Jun. 30, 2026	Jun. 30, 2025
Cash flows from operating activities
Net loss	$ (7,103)	$ (1,931)	$ (13,305)	$ (3,433)
Loss from discontinued operations	(46)	(256)	(23)	(385)
Net loss from continuing operations	(7,057)	(1,675)	(13,282)	(3,048)
Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation			341	276
Depreciation	358	1	362	2
Amortization of debt discount and debt issuance costs			934	0
Non-cash interest expense			406	0
Change in fair value of derivative liability	(47)	0	(80)	0
Amortization of right-of-use asset			428	0
Changes in operating assets and liabilities:
Prepaid expenses and other current assets			(178)	(113)
Inventory			(750)	0
Other assets			(90)	(2)
Accounts payable			375	109
Accrued expenses			1,455	353
Lease liabilities			(242)	0
Net cash used in operating activities - continuing operations			(10,321)	(2,423)
Net cash provided by (used in) operating activities - discontinued operations			29	(293)
Net cash used in operating activities			(10,292)	(2,716)
Cash flows from investing activities
Acquisition of property and equipment			(64)	(3)
Acquisition of licensed technology			0	(543)
Net cash used in investing activities			(64)	(546)
Cash flows from financing activities
Proceeds from issuance of common stock, net of issuance costs			69	1,908
Proceeds from issuance of preferred stock and common stock warrants, net of issuance costs			241	585
Proceeds from warrant exercises, net of fees			(3)	109
Offering costs in advance of sale of common stock			(120)	(158)
Net cash provided by financing activities			187	2,444
Net decrease in cash and cash equivalents			(10,169)	(818)
Beginning of period			12,645	2,002
End of period	2,476	1,184	2,476	1,184
Less: Cash and cash equivalents included in discontinued operations	0	0	0	0
Cash and cash equivalents included in continuing operations	2,476	1,184	2,476	1,184
Cash and cash equivalents	2,108	1,184	2,108	1,184
Restricted cash	368	0	368	0
Total cash and cash equivalents included in continuing operations	$ 2,476	$ 1,184	2,476	1,184
Supplemental disclosure on non-cash investing and financing activities
Issuance of common stock warrant			0	36
Dividends declared			235	0
Lease liabilities arising from right-of-use assets			10,264	0
Restricted Stock Units (RSUs) [Member]
Supplemental disclosure on non-cash investing and financing activities
Issuance of equity			0	0
Issuance of equity			0	0
Issuance of Stock in Exchange for License [Member]
Supplemental disclosure on non-cash investing and financing activities
Issuance of equity			0	1,700
Issuance of equity			0	1,700
Issuance of Stock for Equity Line of Credit [Member]
Supplemental disclosure on non-cash investing and financing activities
Issuance of equity			375	94
Issuance of equity			$ 375	$ 94